Key Takeaways
- • William Blair has acquired Armentum Partners, a boutique advisory firm focused on debt financing, alternative capital solutions and royalty monetization, marking the firm's second investment banking transaction of 2026.
- • Armentum has raised more than $22 billion across more than 390 transactions since inception, according to the company, and its senior bankers bring more than 200 years of combined experience.
- • All Armentum professionals join William Blair with client relationships intact, and the deal opens a new William Blair office in Menlo Park, California, expanding its Silicon Valley presence.
- • Financial terms of the transaction were not disclosed, and Armentum will continue operating under its existing name for a period after closing.
- • Clearsight Advisors served as financial advisor to Armentum Partners on the transaction.
Summary
William Blair has acquired Armentum Partners, a boutique advisory firm specializing in debt financing, alternative capital solutions and royalty monetization. The acquisition expands William Blair's investment banking capabilities across healthcare, technology and venture-backed businesses and marks the firm's second investment banking transaction of 2026. Financial terms were not disclosed.
Armentum advises venture-backed companies, publicly traded businesses and academic institutions on specialized financing, including enterprise value lending, asset-based financing and royalty monetization. According to the company, Armentum has raised more than $22 billion since its inception across more than 390 transactions. Its senior bankers collectively bring more than 200 years of experience spanning investment banking, commercial lending, venture financing, private and public equity investing, and business development. Its royalty monetization work, which provides upfront capital in exchange for rights to future revenue from licensed technologies or pharmaceutical products, is particularly relevant to biotechnology businesses and research institutions.
Matt Zimmer, Global Head of Investment Banking at William Blair, said the acquisition supports the firm's strategy of serving innovative companies and institutions across the venture capital, public company and collegiate communities. Steve Maletzky, Head of Capital Markets, described the deal as "a natural synergistic extension of our capital markets strategy," adding that Armentum's lender relationships will complement the firm's broader capital markets operations. Hutch Corbett of Armentum said the combined platform will give clients access to public and private equity capital raising, mergers and acquisitions advisory, secondary advisory, primary fund raising and equity research.
The move comes as private credit and direct lending have become increasingly important alternatives for companies seeking flexible capital. William Blair identified healthcare innovation, artificial intelligence, software, fintech, industrial technology and acquisition financing as areas of growing demand for alternative capital. The acquisition also complements the firm's recent life sciences investment banking hires, including Michael Allwin as Head of Biopharma Investment Banking, Emanuela Branchetti as Managing Director of Scientific Affairs, and Alethia Young in equity research.
All Armentum professionals are joining William Blair, and the firm will open a Menlo Park office. Armentum has professionals in Boston, Chicago, Menlo Park, New York, Philadelphia and San Francisco. Armentum will continue operating under its existing name for a period following closing, and the companies did not specify when full integration will occur. Clearsight Advisors served as financial advisor to Armentum. William Blair's investment banking group operates across more than 20 cities on four continents and advised on more than $880 billion in completed transaction volume from July 2021 through June 2026.
Armentum advises venture-backed companies, publicly traded businesses and academic institutions on specialized financing, including enterprise value lending, asset-based financing and royalty monetization. According to the company, Armentum has raised more than $22 billion since its inception across more than 390 transactions. Its senior bankers collectively bring more than 200 years of experience spanning investment banking, commercial lending, venture financing, private and public equity investing, and business development. Its royalty monetization work, which provides upfront capital in exchange for rights to future revenue from licensed technologies or pharmaceutical products, is particularly relevant to biotechnology businesses and research institutions.
Matt Zimmer, Global Head of Investment Banking at William Blair, said the acquisition supports the firm's strategy of serving innovative companies and institutions across the venture capital, public company and collegiate communities. Steve Maletzky, Head of Capital Markets, described the deal as "a natural synergistic extension of our capital markets strategy," adding that Armentum's lender relationships will complement the firm's broader capital markets operations. Hutch Corbett of Armentum said the combined platform will give clients access to public and private equity capital raising, mergers and acquisitions advisory, secondary advisory, primary fund raising and equity research.
The move comes as private credit and direct lending have become increasingly important alternatives for companies seeking flexible capital. William Blair identified healthcare innovation, artificial intelligence, software, fintech, industrial technology and acquisition financing as areas of growing demand for alternative capital. The acquisition also complements the firm's recent life sciences investment banking hires, including Michael Allwin as Head of Biopharma Investment Banking, Emanuela Branchetti as Managing Director of Scientific Affairs, and Alethia Young in equity research.
All Armentum professionals are joining William Blair, and the firm will open a Menlo Park office. Armentum has professionals in Boston, Chicago, Menlo Park, New York, Philadelphia and San Francisco. Armentum will continue operating under its existing name for a period following closing, and the companies did not specify when full integration will occur. Clearsight Advisors served as financial advisor to Armentum. William Blair's investment banking group operates across more than 20 cities on four continents and advised on more than $880 billion in completed transaction volume from July 2021 through June 2026.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.